Precigen (PGEN) 2025 Earnings Outlook: What to Watch
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Understand when rebalancing triggers capital gains taxes and how to plan for them. This intro highlights key rules and proactive strategies.
23,600 articlesAs biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
A new study shows Atlanta's rise as a hub for institutional single-family rentals, driving up loan demand and alterin...
California luxury builder Thomas James Homes announces a new growth plan under CEO Steve Schlageter, centering on pre...
The SEC outlines a two-stage approach to on-chain trading, echoing lessons from the 1990s as it weighs how crypto ven...
Peloton has faced a brutal selloff, but the story isn’t finished. This article dives into whether Peloton is broken o...
Binance’s delisting of five smaller tokens sparked a brutal price collapse altcoins, with double-digit losses across ...
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
SpaceX is charging toward a historic IPO, aiming for a mid-June pricing and a Nasdaq debut under SPCX. The deal could...
Ginnie Mae’s Joseph Gormley warns that risk-layered FHA portfolios pose new challenges for lenders and investors as l...
A 49-year-old mother considers tapping home equity to fund a $65k-per-year college. The decision could push retiremen...
Toll Brothers raises its 2026 delivery guidance on persistent luxury demand and better-than-expected absorption. The ...